JP2003524421A5 - - Google Patents

Download PDF

Info

Publication number
JP2003524421A5
JP2003524421A5 JP2001561344A JP2001561344A JP2003524421A5 JP 2003524421 A5 JP2003524421 A5 JP 2003524421A5 JP 2001561344 A JP2001561344 A JP 2001561344A JP 2001561344 A JP2001561344 A JP 2001561344A JP 2003524421 A5 JP2003524421 A5 JP 2003524421A5
Authority
JP
Japan
Prior art keywords
composition according
composition
lipase
protease
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001561344A
Other languages
English (en)
Japanese (ja)
Other versions
JP5217050B2 (ja
JP2003524421A (ja
Filing date
Publication date
Priority claimed from US09/791,947 external-priority patent/US20010046493A1/en
Application filed filed Critical
Publication of JP2003524421A publication Critical patent/JP2003524421A/ja
Publication of JP2003524421A5 publication Critical patent/JP2003524421A5/ja
Application granted granted Critical
Publication of JP5217050B2 publication Critical patent/JP5217050B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001561344A 2000-02-24 2001-02-23 リパーゼ含有組成物およびこれらの使用方法 Expired - Fee Related JP5217050B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18451700P 2000-02-24 2000-02-24
US60/184,517 2000-02-24
US09/791,947 US20010046493A1 (en) 2000-02-24 2001-02-22 Lipase-containing composition and methods of use thereof
US09/791,947 2001-02-22
PCT/US2001/006074 WO2001062280A2 (en) 2000-02-24 2001-02-23 Lipase-containing composition and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011260721A Division JP2012040028A (ja) 2000-02-24 2011-11-29 リパーゼ含有組成物およびこれらの使用方法

Publications (3)

Publication Number Publication Date
JP2003524421A JP2003524421A (ja) 2003-08-19
JP2003524421A5 true JP2003524421A5 (https=) 2008-04-03
JP5217050B2 JP5217050B2 (ja) 2013-06-19

Family

ID=26880199

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001561344A Expired - Fee Related JP5217050B2 (ja) 2000-02-24 2001-02-23 リパーゼ含有組成物およびこれらの使用方法
JP2011260721A Pending JP2012040028A (ja) 2000-02-24 2011-11-29 リパーゼ含有組成物およびこれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011260721A Pending JP2012040028A (ja) 2000-02-24 2011-11-29 リパーゼ含有組成物およびこれらの使用方法

Country Status (11)

Country Link
US (4) US20010046493A1 (https=)
EP (1) EP1261368B1 (https=)
JP (2) JP5217050B2 (https=)
AT (1) ATE465748T1 (https=)
AU (1) AU2001249072B2 (https=)
DE (1) DE60141950D1 (https=)
DK (1) DK1261368T3 (https=)
ES (1) ES2345032T3 (https=)
IL (1) IL151313A0 (https=)
PT (1) PT1261368E (https=)
WO (1) WO2001062280A2 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
AU2002364750A1 (en) * 2001-12-14 2003-06-30 Solvay Pharmaceuticals Gmbh Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
KR20040012305A (ko) * 2002-08-02 2004-02-11 김영권 리파아제를 생산능을 가지는 신규한 불콜데리아멀티보란스 ｄｈ4와 이를 이용한 리파아제 생산방법
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
KR20060127857A (ko) * 2003-10-29 2006-12-13 알투스 파마슈티컬스 인코포레이티드 혈장 콜레시스토키닌(ｃｃｋ) 농도 조절 및 통증 치료를위한 비-췌장 프로테아제
JP2005222035A (ja) * 2004-01-09 2005-08-18 Canon Inc 電子写真画像形成装置
CA2554033C (en) * 2004-01-28 2013-04-02 Csir Stabilization of enzymes
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
EP2422804A1 (en) * 2004-06-17 2012-02-29 Amano Enzyme USA., Ltd. Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
PT1809320E (pt) * 2004-10-14 2010-10-25 Altus Pharmaceuticals Inc Composições contendo lipase, protease e amilase para o tratamento de insuficiência pancreática
JP5199077B2 (ja) * 2005-06-10 2013-05-15 アルタス ファーマシューティカルズ インコーポレイテッド シュウ酸オキシダーゼ結晶の投与による、シュウ酸塩濃度を低下させるための方法
AU2006261444A1 (en) * 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20080199448A1 (en) * 2007-02-16 2008-08-21 Ross Mairi R Enzyme composition for improving food digestion
US8246950B2 (en) * 2007-02-20 2012-08-21 Aptalis Pharma Limited Stable digestive enzyme compositions
CA2702577A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
US8784884B2 (en) 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
SE535296C2 (sv) 2010-09-08 2012-06-19 Anara Ab Mognad av mag-tarmkanalen
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
CA2884592C (en) 2012-09-19 2021-08-31 Grespo Ab Compositions for improvement of brain function
EP2996712B1 (en) 2013-03-15 2018-10-31 Allergan Pharmaceuticals International Limited Process for the preparation of a composition containing digestive enzymes and nutrients suitable for enteral administration
WO2015019198A2 (en) 2013-07-22 2015-02-12 Aptalis Pharma S.R.L. High potency pancreatin pharmaceutical compositions
MX2016001593A (es) 2013-08-09 2016-09-29 Allergan Pharmaceuticals Int Ltd Composicion de enzima digestiva adecuada para administracion enterica.
MX2016000480A (es) 2013-11-05 2016-10-21 Allergan Pharmaceuticals Int Ltd Composiciones farmaceuticas de pancreatina de alta potencia.
JP2017519490A (ja) 2014-06-19 2017-07-20 アプタリス ファルマ リミテッド 膵臓抽出物からのウイルス汚染の除去方法
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2016126970A1 (en) * 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
BR112018003766A2 (pt) 2015-08-28 2018-09-25 Unilever Nv composição detergente líquida compreendendo enzima protease e não protease
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
US10560349B2 (en) 2018-01-31 2020-02-11 Salesforce.Com, Inc. Data consistency of policy enforcement for distributed applications
EP4501403A3 (en) * 2019-08-30 2025-05-14 Société des Produits Nestlé S.A. Engineered lipase variants

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944470A (en) * 1973-06-29 1976-03-16 The Procter & Gamble Company Stabilization and enhancement of enzymatic activity
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4659667A (en) * 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
DK154572C (da) * 1985-08-07 1989-04-24 Novo Industri As Enzymatisk detergentadditiv, detergent og fremgangsmaade til vask af tekstiler
JP3079276B2 (ja) * 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
DE3808695A1 (de) * 1988-03-16 1989-10-05 Henkel Kgaa Fluessiges waschmittel
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
US5618710A (en) * 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
US5892013A (en) * 1990-09-13 1999-04-06 Novo Nordisk A/S Lipase variants
CA2110497C (en) * 1991-07-01 2005-04-19 Reinhard Braatz Use of bacterial lipases for producing drugs for maldigestion therapy
WO1993013200A1 (en) * 1991-12-20 1993-07-08 Novo Nordisk A/S A process for the preparation of lipase
DK0671943T3 (da) * 1992-06-30 2000-03-27 Cortecs Uk Ltd Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré
DK154292D0 (da) * 1992-12-23 1992-12-23 Novo Nordisk As Nyt enzym
DK39693D0 (da) * 1993-04-02 1993-04-02 Novo Nordisk As Enzym
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
GB9403344D0 (en) * 1994-02-22 1994-04-13 Cortecs Ltd Medical application of bromelain
DE4408152A1 (de) * 1994-03-11 1995-09-14 Studiengesellschaft Kohle Mbh Immobilisierte Lipasen in hydrophoben Sol-Gel-Materialien
WO1995030744A2 (en) * 1994-05-04 1995-11-16 Genencor International Inc. Lipases with improved surfactant resistance
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH08264685A (ja) * 1995-03-27 1996-10-11 Toshiba Corp 樹脂封止型半導体装置及びその製造方法
US6051220A (en) * 1995-05-31 2000-04-18 Medzyme N.V. And Simon Lodewijk Scharpe Composition to improve digestibility and utilization of nutrients
US5932212A (en) * 1996-05-24 1999-08-03 Altus Biologics, Inc. Crosslinked protein crystal formulations and their use as catalysts in organic solvents
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
US5843296A (en) * 1996-12-26 1998-12-01 Digital Matrix Method for electroforming an optical disk stamper
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6013680A (en) * 1997-10-21 2000-01-11 Amano Pharmaceutical Co., Ltd. Digestive enzyme-containing medicament
WO1999055310A1 (en) * 1998-04-27 1999-11-04 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US6156552A (en) * 1998-02-18 2000-12-05 Novo Nordisk A/S Lipase variants
US6042823A (en) * 1998-07-02 2000-03-28 Amano Pharmaceuticals Co., Ltd. Enzyme composition and use thereof
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
PT1809320E (pt) * 2004-10-14 2010-10-25 Altus Pharmaceuticals Inc Composições contendo lipase, protease e amilase para o tratamento de insuficiência pancreática

Similar Documents

Publication Publication Date Title
JP2003524421A5 (https=)
CA2228389C (en) High buffer-containing enteric coated digestive enzyme bile-acid compositions and method of treating digestive disorders therewith
HRP20161684T1 (hr) Pripravci koji sadrže lipazu, proteazu i amilazu, namijenjeni liječenju insuficijencije gušterače
World Health Organization Meningococcal meningitis: Overview= Méningite à méningocoques: Généralités
DeGroot et al. Encapsulation of urease in alginate beads and protection from α-chymotrypsin with chitosan membranes
DE69808402D1 (de) Arzneimittel zur Behandlung von durch Hernie gestörter intervertebraler Bandscheibe
CA2257121A1 (en) Methods and compositions for treating urinary incontinence using optically pure (s)-oxybutynin
WO2002096392A1 (en) Taste-masking of highly water-soluble drugs
MXPA03006364A (es) TRATAMIENTO DE PERTURBACIONES DEL SUEnO.
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
DE60202794D1 (de) Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür
AU2223095A (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
JP2007509982A5 (https=)
EP1663177B1 (en) Topical preparations comprising a hydrophilic carrier and a silicone matrix
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2011228743A1 (en) Gastro-resistant enzyme pharmaceutical compositions
IL150818A0 (en) Composition for intestinal delivery
SA110310695B1 (ar) تراكيب الإنزيم البنكرياسي وطرق لمعالجة التهاب البنكرياس والقصور البنكرياسي
US11464834B2 (en) Orodispersible tablet containing burlulipase and pharmaceutical composition produced therefrom
AU5802299A (en) Extended release acetaminophen
CN117860718A (zh) 金刚烷胺组合物、其制备和使用方法
JP2023018079A (ja) 消化障害の予防および／または処置用の医薬組成物およびそれを製造する方法、並びにそれを含む医薬製品
CA2386547A1 (en) Orally disintegrating composition comprising mirtazapine
GB2398005A (en) Orally administrable pharmaceutical formulation
JPS62142113A (ja) 口腔粘膜付着用錠剤